Ta Win makes foray into pharma industry, invests RM20.8m in Royce Pharma


From left are Royce Pharma Manufacturing president Zainal Ariff Tan Sri Mahmood and group deputy president Datuk Chandrasekar Suppiah; Deputy Human Resources Minister Awang Hashim Awang Hashim while Ta Win Holdings was presented by its group managing director Datuk Seri Ngu Tieng Ung and executive director Tan Poo Chuan.

KUALA LUMPUR: Ta Win Holdings Bhd’s subsidiary is venturing into the pharmaceutical industry through its RM20.85mil investment in Royce Pharma Manufacturing Sdn Bhd.

It said in a statement on Monday its healthcare arm Ta Win Copper Biohealth Sdn Bhd (TWCB) agreed to acquire a 32.5% stake in Royce Pharma, marking the first investment in the pharmaceutical industry.

Play, subscribe and stand a chance to win prizes worth over RM39,000! T&C applies.

Monthly Plan

RM 13.90/month

RM 11.12/month

Billed as RM 11.12 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 9.87/month

Billed as RM 118.40 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Next In Business News

US weekly jobless claims decline as labor market remains stable
MIER: US-Iran conflict to impact business performance over the next two to three months
JCBNext trims stake in Taiwanese-listed 104 Corp
Auditors flag Rimbunan Sawit as liabilities exceeding assets
Ancom Nylex stays positive amid volatility on higher solvent prices
Ringgit rebounds vs US dollar ahead of 1Q GDP estimate tomorrow
Zetrix to manage Socso’s self-employment social security scheme
Solution Group redesignates Lim Yong Hew to executive chairman
Plenitude appoints Ng Yoon Thai as CEO
Green Packet inks MoU with Presma to transform Muslim F&B sector

Others Also Read